1-8 of 8
Chronic Lymphocytic Leukemia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study

Open Access
Priyanka Pullarkat, Matthew Lei, Robert Redd, Ruchi Rana, Uvette Lou, Mark Sorial, Brenna Rowen, E. Bridget Kim, Andrea Medrano, J. Erika Haydu, Jeffrey Barnes, Ephraim Hochberg, P. Connor Johnson, Ronald Takvorian, Julia Lynch, Emily Patterson, Katherine Thorp, Maryanne Sherburne, Brianne McGree, Josie Ford, Ronald Nemec, Catherine Cho, Jeremy Abramson, Jacob D. Soumerai
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (2): 100075.
https://doi.org/10.1016/j.bneo.2025.100075
Published: 2025
Journal Articles

Adult leukemia in Florida 2010-2019: diverse, aging population as an indicator for the United States

Open Access
Clinical Trials & Observations
Ming S. Lee, Rebecca E. Kaiser, Christopher D. Armstrong, David B. Dukenik, Nancy S. Elliott, Raymond R. Balise, Justin M. Watts, Mikkael A. Sekeres, Erin N. Kobetz, Justin Taylor
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (2): 100078.
https://doi.org/10.1016/j.bneo.2025.100078
Published: 2025
Journal Articles

Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemia

Open Access
Olivia M. Depies, Qianqian Guo, Yuan Gao, Sutapa Sinha, Zhenqing Ye, Weiguo Han, Kari G. Rabe, Mingma S. Hoel, Heather C. Darby, Chuanhe Yu, Esteban Braggio, Sameer A. Parikh, Susan L. Slager, Neil E. Kay, Zhiquan Wang
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (1): 100059.
https://doi.org/10.1016/j.bneo.2024.100059
Published: 2025
Includes: Supplemental data
Journal Articles

Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

Open Access
Ramsay Hafer, Francesco Iadevaia, Thomas Z. Rohan, Teresa Duong, Maria Poluch, Gina Keiffer, Michael Li, Andres Ferber, Luca Laurenti, Alan S. Khoo, Pierluigi Porcu
Journal: Blood Neoplasia
Blood Neoplasia (2025) 2 (1): 100064.
https://doi.org/10.1016/j.bneo.2024.100064
Published: 2025
Includes: Supplemental data
Journal Articles

Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United States

Open Access
Matthew S. Davids, Jacob Ambrose, Enrico de Nigris, Jennifer Prescott, Siyang Leng, Mohammed Z. H. Farooqui, Shravanthi R. Gandra, Christina M. Zettler, Laura L. Fernandes, Ching Kun Wang, Mazyar Shadman
Journal: Blood Neoplasia
Blood Neoplasia (2024) 2 (1): 100047.
https://doi.org/10.1016/j.bneo.2024.100047
Published: 2024
Includes: Supplemental data
Journal Articles

COVID-19 vaccination in patients with classic and variant hairy cell leukemia

Free
Robert J. Kreitman, Lacey James, Julie Feurtado, Holly Eager, Olena Sierra Ortiz, Mory Gould, Isaac Shpilman, Hong Zhou, Peter D. Burbelo, Jeffrey I. Cohen, Hao-Wei Wang, Constance M. Yuan, Evgeny Arons
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (4): 100035.
https://doi.org/10.1016/j.bneo.2024.100035
Published: 2024
Journal Articles

Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practice

Free
Natalia Timofeeva, Nitin Jain, Varsha Gandhi
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (3): 100034.
https://doi.org/10.1016/j.bneo.2024.100034
Published: 2024
Journal Articles

Frequent response monitoring in chronic lymphocytic leukemia clinical trials: what is the value?

Free
Agnes Mattsson, Jeanette Lundin, Tom A. Mulder, Sandra E. Sylvan, Marzia Palma, Lotta Hansson, Anders Österborg
Journal: Blood Neoplasia
Blood Neoplasia (2024) 1 (2): 100006.
https://doi.org/10.1016/j.bneo.2024.100006
Published: 2024